Personalized Medicine and the Future of Pathology at Penn Medicine

David B. Roth, MD, PhD, offers an overview of the Center for Personalized Diagnostics (CPD), where pathologists are performing large-scale, massively parallel DNA sequencing and chromosomal analysis to identify genomic alterations in hematologic and solid tumor cancers. The CPD is a joint effort of Penn Medicine and the Abramson Cancer Center.

Related Links

• View Clinical Briefing: Personalized Diagnostics for Hematologic and Solid Tumor Cancers
• View Case Study: A 43-year-old man with IV non-small cell lung cancer identified with the tyrosine kinase mutation EML4-ALK.
• View Dr Roth's Profile